Bo Liang is the founder of iVIEW Therapeutics. iVIEW Therapeutics has raised $31M in total funding. Latest round: Series B.
Bo Liang is the Chief Executive Officer of iVIEW Therapeutics, a clinical-stage biotechnology company focused on innovative ophthalmic therapeutics. He leads the company's efforts to advance ocular drug development programs, including Phase 1/2 trials for dry eye disease and Phase 2 trials for acute adenoviral conjunctivitis.
Full founder directory · Investor directory · Company funding database · Fundraising library